169 related articles for article (PubMed ID: 29297092)
1. Conjunctival melanoma: association of cyclooxygenase-2 tumor expression to prognosis.
Pinto-Proença R; Santos M; Fonseca C; Fernandes J; Gaspar MF; Proença R
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):989-995. PubMed ID: 29297092
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
4. [Pathology and prognostic factors of conjunctival melanoma].
Berta-Antalics AI; Kruse FE; Holbach L
Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
[TBL] [Abstract][Full Text] [Related]
5. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma.
Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
Melanoma Res; 2016 Oct; 26(5):448-56. PubMed ID: 27391144
[TBL] [Abstract][Full Text] [Related]
7. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
9. American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes.
Shields CL; Kaliki S; Al-Dahmash SA; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2012; 28(5):313-23. PubMed ID: 22965011
[TBL] [Abstract][Full Text] [Related]
10. Expression of COX-2 and prognostic outcome in uveal melanoma.
Cryan LM; Paraoan L; Hiscott P; Damato BE; Grierson I; Gray D; Farrell M; Doherty GA; Fitzgerald DJ; O'Brien C
Curr Eye Res; 2008 Feb; 33(2):177-84. PubMed ID: 18293189
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.
Yousef YA; Finger PT
Arch Ophthalmol; 2012 May; 130(5):599-606. PubMed ID: 22652846
[TBL] [Abstract][Full Text] [Related]
12. Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens-Tumor Metastasis by Migration?
Kakkassery V; Winterhalter S; Nick AC; Joachim SC; Joussen AM; Kociok N
Curr Eye Res; 2017 Oct; 42(10):1382-1388. PubMed ID: 28622066
[TBL] [Abstract][Full Text] [Related]
13. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
14. Expression of thymidine phosphorylase and cyclooxygenase-2 in melanoma.
Minisini AM; Pascoletti G; Intersimone D; Poletto E; Driol P; Spizzo R; Scott CA; Puglisi F; Fasola G; Di Loreto C
Melanoma Res; 2013 Apr; 23(2):96-101. PubMed ID: 23411479
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and pathological features of 26 cases of conjunctival melanoma].
Lin JY; Liu D; Li EJ
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):308-11. PubMed ID: 20654056
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated lymphangiogenesis in the development of conjunctival melanoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7074-83. PubMed ID: 21849428
[TBL] [Abstract][Full Text] [Related]
17. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.
Lange CA; Tisch-Rottensteiner J; Böhringer D; Martin G; Schwartzkopff J; Auw-Haedrich C
Ophthalmology; 2012 Sep; 119(9):1924-9. PubMed ID: 22658715
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival Melanoma in Chinese Patients: Local Recurrence, Metastasis, Mortality, and Comparisons With Caucasian Patients.
Zhou C; Wang Y; Jia R; Fan X
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5452-5459. PubMed ID: 29059312
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated lymphangiogenesis in the development of conjunctival squamous cell carcinoma.
Heindl LM; Hofmann-Rummelt C; Adler W; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Apr; 117(4):649-58. PubMed ID: 20346821
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.
Paridaens AD; Minassian DC; McCartney AC; Hungerford JL
Br J Ophthalmol; 1994 Apr; 78(4):252-9. PubMed ID: 8199108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]